NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
Left frame: Normally, tumor cells (purple) evade the immune system’s T cells (...
Medical Product Alert N°8/2022: Substandard (contaminated) METHOTREX 50mg
This WHO Medical Product Alert refers to one batch of substandard (contaminated) METHOTREXTM (methotrexate) 50mg, identified in two countries (Yemen and Lebanon) in the WHO Eastern Mediterranean region. Methotrexate is on the WHO model list of...
One Health in G20 countries
The G20 countries are looking for guidance from the One Health Quadripartite in operationalizing One Health (OH) approaches. In 2022, the Quadripartite supported the Indonesian G20 Presidency by developing the Lombok G20 One Health Policy Brief....
WHO updates recommendations on HPV vaccination schedule
In a new position paper, WHO has updated its recommendations for the human papillomavirus (HPV) vaccine. Of particular note, the paper states that a single-dose schedule, referred to as an alternative, off-label single–dose schedule can provide a...
NIH researchers use 3D bioprinting to create eye tissue
Growth of blood vessels across printed rows of an endothelial-pericyte-fibroblast cell mixture. By day 7, blood...
2022 Year In health: New Ebola and cholera outbreaks, mpox emergency, COVID-19 ‘not over’
A health worker in Motema Pembe area prepares for a household decontamination in...
The Quadripartite establishes the Quadripartite Technical Group on Antimicrobial Resistance and Use Integrated Surveillance (QTG-AIS)
Antimicrobial resistance (AMR) is a global threat to animal and human health, food security, economic growth, and development. It is mostly driven by the inappropriate use of antimicrobials in human, animal, and plant health, food production, and...
WHO announces landmark changes in treatment of drug-resistant tuberculosis
WHO has just released updated consolidated guidelines on the treatment of drug-resistant TB (DR-TB) featuring major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB). The guidelines...
NIH-funded study finds hepatitis C treatment gap for individuals with alcohol use disorder
new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines recommending antiviral treatment regardless of alcohol...
NIH launches harm reduction research network to prevent overdose fatalities
Close-up of a person's hands holding a red bag with a box of naloxone nasal spray inside.
